CSI Market
Sign In | Register

Nutra Pharma (NPHC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NPHC Annual Cash Flow →
The data below summarizes Nutra Pharma's cash flow activity from Jun 30 2025 to Jun 30 2026, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-8.36
Depreciation & amortization0.00
Amortization of Other Assets0.13
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.05
Increase (Decrease) in Inventories0.40
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.01
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.14
Gain Loss On Settlement Of Accounts Payable-
Gain Loss On Loan Modification-
Gain Loss On Note Payable Default-
Derivative Gain Loss On Derivative Net-
Loan Origination Fees Paid-
Amortization Of Loan Discount-
Rental Income Nonoperating-
Loan Processing Fee-
Interest Income Expense Net-
Extinguishment Of Debt Gain Loss Net Of Tax-
Debt Conversion Original Debt Amount-
Accrued Interest Expense For Amount Due To Officer-
Stockbased Loan Modification Cost-
Change In Fair Value Of Convertible Notes And Derivatives0.12
Amortization Of Operating Lease Rightofuse Assets-
Increase Decrease In Contract With Customer Liability-
Operating Lease Right Of Use Asset Amortization Expense-
Change In Reserve For Supplier Advances For Purchases-
Increase Decrease In Deferred Revenue Related Party-
Income taxes0.00
Gain (Loss) on Sale of Derivatives0.00
Accounts Receivable0.01
Increase (Decrease) in Accounts Payable, Trade0.04
Accrued Expense0.28
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities6.70
Discontinued operations0.00
Net Cash flow from Operating Activities-0.58
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.08
Other borrowing transactions0.00
Long-term debt - borrowings0.72
Long-term debt - repayments-0.23
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Repayment Of Subscriptions Receivable-
Proceeds From Issuance Common Stock Purchase Agreement-
Common Stock Issued For Cash-
Proceeds From Other Notes Payable-
Repayments Other Notes Payable-
Proceeds From Notes Payable Related Party-
Repayments Notes Payable Related Party-
Net Decrease Increase In Cash-
Repayments Of Notes Payablerelated Party-
Repayments Of Notes Payable Related Party-
Repayments Of Other Notes Payable-
Proceeds From Loans From Officer-
Repayments Of Officers Loans-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.57
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.58
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Nutra Pharma cash flow history.

Sign In Create Free Account

About Nutra Pharma Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 19, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-039166

Figures are derived from filed reports and may be restated. Historical data is subject to revision.